NAD+

What is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a substance naturally found in virtually every cell of the body. It helps cells turn nutrients into usable energy and supports processes involved in DNA repair and cellular maintenance.

Although NAD+ is frequently discussed alongside peptides, NAD+ is not a peptide. It is a coenzyme—a small molecule that helps other proteins and enzymes perform essential jobs.

Scientists are interested in NAD+ because its availability and regulation may change with age, illness, and metabolic stress. These patterns differ across tissues and individuals, so it is too simplistic to say that everyone's NAD+ levels inevitably decline with age.

How does NAD+ work?

Think of NAD+ as a key participant in the cell's energy and maintenance systems. It has two especially important roles:

• Energy production: NAD+ helps transfer electrons during the chemical reactions that allow cells to produce ATP, the body's main usable energy currency.
• Cellular maintenance: Enzymes involved in DNA repair, stress responses, and cell signaling use NAD+ as part of their activity.

The body continually makes and recycles NAD+ using nutrients and related compounds, including forms of vitamin B3. Researchers are studying whether supporting these pathways can improve health outcomes—not simply increase a laboratory measurement.

What has research found?

Laboratory and animal research

Preclinical studies have linked NAD+ metabolism to mitochondrial function, cellular stress responses, and aspects of age-related biology. These studies provide a strong scientific rationale for further investigation, but results in cells or animals cannot establish human benefits.

Human studies of NAD+ precursors

Most human intervention research has examined compounds the body can use to make NAD+, particularly nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Trials commonly find increases in blood or cellular NAD-related measurements. However, improvements in energy, physical performance, metabolic health, or other meaningful outcomes have been inconsistent.

Human studies of intravenous NAD+

Direct IV NAD+ has much less clinical evidence. Small pilot and observational studies have explored how it is processed and tolerated, but have not established that infusions slow aging, reliably improve energy, or produce lasting wellness benefits. A 2026 systematic review found the evidence for meaningful anti-aging and wellness outcomes remains inconclusive.

What do we know about safety?

Safety depends on the exact compound, formulation, dose, and route of administration. Oral NR and NMN have generally been tolerated in short- to medium-term clinical trials, but those findings do not establish the safety of IV NAD+.

Small IV NAD+ studies have reported nausea, abdominal cramping, chest pressure, and other symptoms during infusion. Long-term safety remains poorly characterized.

The FDA has specifically warned that food-grade NAD+ ingredients may be unsuitable for preparing sterile injectable products. It has received reports of severe chills, shaking, vomiting, and fatigue after injectable NAD+ products, with some patients requiring medical care. These reactions are consistent with possible endotoxin contamination; a reported event does not by itself establish the precise cause.

Is NAD+ FDA-approved?

There is no FDA-approved intravenous NAD+ treatment for anti-aging or general wellness. NAD+ infusions marketed in wellness settings should not be confused with FDA-approved therapies supported by large clinical outcome trials.

NAD+ itself is a normal part of human biology, and NAD-related nutrients or supplements are a separate category from sterile injectable drugs. The regulatory and safety considerations are not interchangeable.

Understanding the research limitations

• NAD+ is not the same as its precursors. Findings from NR, NMN, or niacin cannot automatically be attributed to an NAD+ infusion.
• Biomarkers are not outcomes. Higher blood NAD+ does not by itself demonstrate more energy, better cognition, or slower aging.
• Route of administration matters. Oral and IV products differ in exposure, tolerability, and quality requirements.
• Small studies have limits. Uncontrolled or retrospective studies cannot reliably distinguish treatment effects from expectations, other lifestyle changes, or selection bias.
• Aging is complex. NAD+ biology is only one part of a much larger network of age-related processes.

The bottom line

NAD+ is essential for energy metabolism and cellular maintenance, making it a compelling subject of research. Human studies show that some oral precursors can raise NAD-related biomarkers, but consistent clinical benefits have not been established. Direct IV NAD+ has even less evidence for meaningful health outcomes, and its safety requires separate consideration.

Scientific interest is justified; claims of proven rejuvenation, improved vitality, or anti-aging benefits are ahead of the available human evidence.

Beyond the Research: What People Are Reporting

NAD+ has become popular in longevity and wellness discussions, particularly around IV infusions and products marketed to support NAD+ levels. Personal accounts describe a wide range of experiences:

• Perceived energy and alertness: Some people describe feeling more energized or less fatigued following treatment.
• Mental clarity: Some report feeling more focused or less mentally foggy.
• Recovery and general well-being: Others describe improved resilience or an overall sense of wellness.
• Uncomfortable infusions: Some report nausea, cramping, or chest discomfort during IV NAD+ administration—symptoms also described in small clinical studies.
• Little or no noticeable difference: Others report no clear change, or find that any perceived effect is short-lived.

Putting these experiences into perspective

These themes help explain interest in NAD+ but are not proof that the intervention caused the reported changes. Expectation, sleep, diet, hydration, other treatments, and natural day-to-day variation can all influence how someone feels. Reports also often combine NAD+ infusions with oral precursors, making comparisons difficult.

These anecdotal themes are illustrative descriptions of publicly discussed experiences, not findings from a systematic collection of verified firsthand reports.